Enterococcus Antigen Antibody Detection Multiresistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Nosocomial infections caused by Enterococcus faecalis and Enterococcus faecium are increasing due to the rise of multiresistant strains, leading to significant morbidity, mortality, and healthcare costs, with existing immunotherapeutic approaches being inadequate in preventing or controlling these infections.
Innovation Solution
Development of novel antigens and antibodies targeting cell wall-associated and capsular polysaccharides of Enterococcus faecalis and Enterococcus faecium, including a specific capsular polysaccharide structure characterized by a disaccharide unit, to facilitate active or passive immunization and detection methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat Enterococcus infections, then initial infections can be controlled, but multiresistant strains develop leading to treatment failure
Solution Approach 1:
The patent converts the harmful effect of antibiotic resistance into a beneficial diagnostic tool by developing antibodies that specifically detect resistant strains. The resistance mechanisms that render antibiotics ineffective are simultaneously used as targets for highly specific antibody-based detection and differentiation of bacterial strains.
Solution Approach 2:
The patent introduces antibody-based diagnostic methods as an intermediary between antibiotic treatment and resistance development. This intermediary system enables early detection of resistant strains, allowing for alternative treatment strategies before resistance fully manifests and undermines conventional therapy.
2Reliability
If immunotherapeutic approaches are developed to prevent Enterococcus infections, then infection rates can be reduced, but adequate protective antibodies must be generated against diverse strains
Solution Approach 1:
The patent develops a universal antibody-based detection system that can identify multiple Enterococcus strains and serotypes through common structural features. The antibodies are designed to recognize conserved epitopes across different strains, enabling a single diagnostic platform to handle diverse pathogens without requiring strain-specific reagents for each variant.
Solution Approach 2:
The patent employs parameter changes in antibody structure and antigen recognition to broaden strain coverage. By modifying antibody specificity parameters and targeting multiple epitope regions, the system achieves enhanced versatility against diverse Enterococcus strains while maintaining high detection reliability.
3Reliability
If carbohydrate antigens are used for vaccine development, then immunogenicity can be enhanced, but complete structural characterization is lacking for most antigens
Solution Approach 1:
The patent uses molecular modeling and computational methods to create virtual copies and structural representations of complex carbohydrate antigens. These computational models serve as proxies for complete structural characterization, enabling prediction of immunogenicity and antibody binding sites without requiring exhaustive experimental structural analysis of each antigen variant.
Data Source
AI summary
The present invention generally relates to the field of detecting and preventing infectious diseases caused by Enterococcus faecalis and/or Enterococcus faecium. More specifically, the invention relates to an Enterococcus faecalis and/or Enterococcus faecium antigen which comprises at least one unit having the following general formula: